Best Buy Co Inc vs Nuwellis Inc — how do they compare? Best Buy Co Inc trades at $83.73 (market cap $17.70B), while Nuwellis Inc trades at $3.32 (market cap $1.17M). The key difference: Best Buy Co Inc is far larger — about 15128.2× Nuwellis Inc's market cap, and Best Buy Co Inc pays a 4.57% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| BBY | NUWE | |
|---|---|---|
Market Cap | $17.70B | $1.17M |
Sector | Consumer Cyclical | Technology |
52-Week High | $84.00 | $558.26 |
52-Week Low | $55.52 | $2.80 |
Enterprise Value | $20.08B | -$636.97K |
Dividend Yield | 4.57% | — |
Signals from Pluang's Aura AI — not financial advice
Best Buy (BBY) trades at $81.65, down 1.39% on the day, with a bullish technical outlook and strong recent earnings beats. The stock shows robust profitability with a 39.1% ROE and trades at attractive valuations (P/E 15.12, P/S 0.41). Recent news highlights leadership changes and strategic shifts toward higher-margin businesses like marketplace and retail media, supported by new product launches such as RGB LED TVs and Meta VR partnerships.
The outlook is cautiously optimistic with a consensus price target of $82.17 offering modest upside. Key opportunities include dividend yield near 5% and earnings momentum, while risks involve revenue declines, competitive pressures, and macroeconomic sensitivity. Analyst sentiment is mixed with 34% buy ratings, reflecting balanced views on growth potential versus execution challenges.
NUWE trades at $2.80, down 7.89% in the last session, with a bearish technical outlook from moving averages. The company reported a net loss of $17.52 million in 2025 despite $8.27 million revenue, reflecting a negative net margin of 217.22%. Recent developments include a CEO transition to Mike McCormick, a $6 million public offering in June 2026, and expansion in pediatric care installations, indicating strategic growth efforts amid financial challenges.
The outlook remains high-risk due to persistent losses and negative ROE/ROA, though low P/E and P/B ratios suggest undervaluation. Analyst sentiment is split evenly between buy and hold. Key risks include cash burn from negative operating cash flow and execution hurdles in scaling commercial adoption. Upside depends on revenue acceleration and cost management under new leadership.
Trailing returns across standard periods
With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Read more on BBY →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →